Outcomes of extracorporeal membrane oxygenation support in the cardiac catheterization laboratory.
Christopher J ParrRajat SharmaRakesh C AroraRohit SingalBrett HiebertKunal MinhasPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)
The use of VA-ECMO in the CCL is feasible, demonstrating 47% 30-day survival, largely persistent to 1 year, in a cohort that otherwise has extremely high mortality.
Keyphrases
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- respiratory failure
- cardiovascular events
- left ventricular
- liver injury
- risk factors
- liver fibrosis
- ultrasound guided
- mechanical ventilation
- free survival
- drug induced
- intensive care unit
- coronary artery disease
- heart failure
- metabolic syndrome